ATE359298T1 - Löslicher laminin rezeptor vorläufer und verfahren zur verhinderung von laminins interaktionen - Google Patents
Löslicher laminin rezeptor vorläufer und verfahren zur verhinderung von laminins interaktionenInfo
- Publication number
- ATE359298T1 ATE359298T1 AT98929404T AT98929404T ATE359298T1 AT E359298 T1 ATE359298 T1 AT E359298T1 AT 98929404 T AT98929404 T AT 98929404T AT 98929404 T AT98929404 T AT 98929404T AT E359298 T1 ATE359298 T1 AT E359298T1
- Authority
- AT
- Austria
- Prior art keywords
- tse
- laminin receptor
- laminin
- relates
- present
- Prior art date
Links
- 102000002297 Laminin Receptors Human genes 0.000 title abstract 10
- 108010000851 Laminin Receptors Proteins 0.000 title abstract 10
- 238000000034 method Methods 0.000 title abstract 6
- 239000002243 precursor Substances 0.000 title abstract 4
- 230000003993 interaction Effects 0.000 title 1
- 208000024777 Prion disease Diseases 0.000 abstract 12
- 208000010544 human prion disease Diseases 0.000 abstract 12
- 230000014509 gene expression Effects 0.000 abstract 3
- 239000003550 marker Substances 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 238000003745 diagnosis Methods 0.000 abstract 2
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000002018 overexpression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
- C07K14/7055—Integrin beta1-subunit-containing molecules, e.g. CD29, CD49
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97108712 | 1997-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE359298T1 true ATE359298T1 (de) | 2007-05-15 |
Family
ID=8226854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98929404T ATE359298T1 (de) | 1997-05-30 | 1998-05-29 | Löslicher laminin rezeptor vorläufer und verfahren zur verhinderung von laminins interaktionen |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP0984987B1 (de) |
| JP (1) | JP2002501385A (de) |
| AT (1) | ATE359298T1 (de) |
| AU (1) | AU7917598A (de) |
| CA (1) | CA2291720A1 (de) |
| DE (1) | DE69837539T2 (de) |
| WO (1) | WO1998053838A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6891082B2 (en) * | 1997-08-01 | 2005-05-10 | The Johns Hopkins University School Of Medicine | Transgenic non-human animals expressing a truncated activintype II receptor |
| DE19918141A1 (de) | 1999-04-21 | 2000-10-26 | Boehringer Ingelheim Vetmed | Verfahren zur Diagnose von übertragbaren Spongiformen Enzephalopathien |
| DE19925073C2 (de) * | 1999-06-01 | 2001-07-19 | Stefan Weiss | Nucleinsäuremoleküle mit spezifischer Erkennung von nativem PrP·S··c·, Herstellung und Verwendung |
| DE10106076A1 (de) * | 2001-02-08 | 2002-08-22 | Susanne Wylezalek | Verwendung von Lathyrus Sativus L. zur Herstellung eines Medikamentes zur Behandlung von BSE und BSE-ähnlichen Krankheiten |
| US20030118585A1 (en) | 2001-10-17 | 2003-06-26 | Agy Therapeutics | Use of protein biomolecular targets in the treatment and visualization of brain tumors |
| DE10346627A1 (de) | 2003-10-08 | 2005-05-19 | Weiss, Stefan, PD Dr. | Single-chain-Antikörper gegen den 37 kDa/67 kDa Lamininrezeptor als Werkzeuge zur Diagnose und Therapie von Prionerkrankungen und Krebs, deren Herstellung und Verwendung |
| GB201519557D0 (en) * | 2015-11-05 | 2015-12-23 | Univ Witwatersrand Jhb | Compounds for use in the treatment of telomere related diseases and/or telomere related medical conditions |
| GB201700529D0 (en) * | 2017-01-12 | 2017-03-01 | Rogers April | Laminin receptor peptide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE68924984T2 (de) * | 1988-05-20 | 1996-05-23 | Jolla Cancer Res Found | Adhäsionsrezeptor für laminin und dessen verwendung. |
| US5180809A (en) * | 1988-05-20 | 1993-01-19 | La Jolla Cancer Research Foundation | Adhesion receptor for laminin and its use |
| ATE177754T1 (de) * | 1991-12-03 | 1999-04-15 | Proteus Molecular Design | Fragmente von prion proteinen. |
| EP0920630B1 (de) * | 1996-05-29 | 2002-07-31 | McGILL UNIVERSITY | Prionbindende proteine und deren verwendungen |
| EP1214943B1 (de) * | 1997-12-16 | 2009-04-01 | University Of Zurich | T-Zellen Therapeutika für übertragbare Spongiforme Encephalopathie und Methode zur Herstellung von nicht infektiösen Blut-Produkten und von Geweben abgeleiteten Produkten |
-
1998
- 1998-05-29 AT AT98929404T patent/ATE359298T1/de not_active IP Right Cessation
- 1998-05-29 DE DE69837539T patent/DE69837539T2/de not_active Expired - Lifetime
- 1998-05-29 EP EP98929404A patent/EP0984987B1/de not_active Expired - Lifetime
- 1998-05-29 AU AU79175/98A patent/AU7917598A/en not_active Abandoned
- 1998-05-29 JP JP50026699A patent/JP2002501385A/ja active Pending
- 1998-05-29 EP EP01108876A patent/EP1127894A1/de not_active Withdrawn
- 1998-05-29 CA CA002291720A patent/CA2291720A1/en not_active Abandoned
- 1998-05-29 WO PCT/EP1998/003220 patent/WO1998053838A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69837539T2 (de) | 2008-01-03 |
| CA2291720A1 (en) | 1998-12-03 |
| DE69837539D1 (de) | 2007-05-24 |
| EP0984987B1 (de) | 2007-04-11 |
| WO1998053838A3 (en) | 1999-05-14 |
| EP1127894A1 (de) | 2001-08-29 |
| WO1998053838A2 (en) | 1998-12-03 |
| AU7917598A (en) | 1998-12-30 |
| EP0984987A2 (de) | 2000-03-15 |
| JP2002501385A (ja) | 2002-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60128249D1 (de) | Verfahren zur diagnose von immunologischer lebensmittelsensitivität | |
| JP2019535015A5 (de) | ||
| WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
| BRPI0410261B8 (pt) | anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3 | |
| ATE359298T1 (de) | Löslicher laminin rezeptor vorläufer und verfahren zur verhinderung von laminins interaktionen | |
| ATE460430T1 (de) | Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper | |
| CA2264939A1 (en) | Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes | |
| CN106461670A (zh) | 糖化蛋白质试验 | |
| DE60025347D1 (de) | Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests | |
| GB2029011A (en) | The use of a synthetic bifunctional ligand for the immunometric determination of the concentration ratio of two solutes | |
| CA2235316A1 (en) | A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd) | |
| CA2566040A1 (en) | Method for increasing the dynamic measuring range of test elements, especially immunological test elements, that are based on specific binding reactions | |
| BR0009843A (pt) | Método de diagnosticar encefalopatias esponjiformes transmissìveis | |
| DE69928507D1 (de) | Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie | |
| DE60318435D1 (de) | Universeller biosensor und verfahren zur verwendung | |
| WO2009066787A1 (ja) | 血液試料の品質評価方法 | |
| Adaszewska et al. | The use of BIOCHIP mosaics in diagnostics of bullous pemphigoid: Evaluation and comparison to conventional multistep procedures | |
| DK1090297T3 (da) | Fremgangsmåde til påvisning af et antistof i en væskepröve | |
| ATE427494T1 (de) | Verfahren zur quantifizierung der akt-protein- expression | |
| WO2006004958A3 (en) | Detection or measurement of antibodies to antigenic proteins in biological tissues or samples | |
| EP0669344A3 (de) | Monoklonaler Antikörper und seine Verwendung in einem Immunoassay. | |
| CA2346406A1 (en) | Detection of pleiotrophin | |
| JPH08304406A (ja) | カリブレーターマトリックス | |
| WO1999047932A3 (en) | Diagnosis of spongiform or de-myelinating disease | |
| DE60038557D1 (en) | Assay |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |